347 related articles for article (PubMed ID: 15028733)
1. Palmitate, but not unsaturated fatty acids, induces the expression of interleukin-6 in human myotubes through proteasome-dependent activation of nuclear factor-kappaB.
Weigert C; Brodbeck K; Staiger H; Kausch C; Machicao F; Häring HU; Schleicher ED
J Biol Chem; 2004 Jun; 279(23):23942-52. PubMed ID: 15028733
[TBL] [Abstract][Full Text] [Related]
2. Cross-talk between interleukin 1beta (IL-1beta) and IL-6 signalling pathways: IL-1beta selectively inhibits IL-6-activated signal transducer and activator of transcription factor 1 (STAT1) by a proteasome-dependent mechanism.
Shen X; Tian Z; Holtzman MJ; Gao B
Biochem J; 2000 Dec; 352 Pt 3(Pt 3):913-9. PubMed ID: 11104703
[TBL] [Abstract][Full Text] [Related]
3. Cross-talk mechanisms in the development of insulin resistance of skeletal muscle cells palmitate rather than tumour necrosis factor inhibits insulin-dependent protein kinase B (PKB)/Akt stimulation and glucose uptake.
Storz P; Döppler H; Wernig A; Pfizenmaier K; Müller G
Eur J Biochem; 1999 Nov; 266(1):17-25. PubMed ID: 10542046
[TBL] [Abstract][Full Text] [Related]
4. Different impacts of saturated and unsaturated free fatty acids on COX-2 expression in C(2)C(12) myotubes.
Kadotani A; Tsuchiya Y; Hatakeyama H; Katagiri H; Kanzaki M
Am J Physiol Endocrinol Metab; 2009 Dec; 297(6):E1291-303. PubMed ID: 19755671
[TBL] [Abstract][Full Text] [Related]
5. Ceramide generation is sufficient to account for the inhibition of the insulin-stimulated PKB pathway in C2C12 skeletal muscle cells pretreated with palmitate.
Schmitz-Peiffer C; Craig DL; Biden TJ
J Biol Chem; 1999 Aug; 274(34):24202-10. PubMed ID: 10446195
[TBL] [Abstract][Full Text] [Related]
6. Palmitate induces interleukin-8 expression in human aortic vascular smooth muscle cells via Toll-like receptor 4/nuclear factor-κB pathway (TLR4/NF-κB-8).
Quan J; Liu J; Gao X; Liu J; Yang H; Chen W; Li W; Li Y; Yang W; Wang B
J Diabetes; 2014 Jan; 6(1):33-41. PubMed ID: 23826669
[TBL] [Abstract][Full Text] [Related]
7. Saturated fatty acids inhibit hepatic insulin action by modulating insulin receptor expression and post-receptor signalling.
Ruddock MW; Stein A; Landaker E; Park J; Cooksey RC; McClain D; Patti ME
J Biochem; 2008 Nov; 144(5):599-607. PubMed ID: 18713797
[TBL] [Abstract][Full Text] [Related]
8. Activation of peroxisome proliferator-activated receptor-{delta} by GW501516 prevents fatty acid-induced nuclear factor-{kappa}B activation and insulin resistance in skeletal muscle cells.
Coll T; Alvarez-Guardia D; Barroso E; Gómez-Foix AM; Palomer X; Laguna JC; Vázquez-Carrera M
Endocrinology; 2010 Apr; 151(4):1560-9. PubMed ID: 20185762
[TBL] [Abstract][Full Text] [Related]
9. Elevated toll-like receptor 4 expression and signaling in muscle from insulin-resistant subjects.
Reyna SM; Ghosh S; Tantiwong P; Meka CS; Eagan P; Jenkinson CP; Cersosimo E; Defronzo RA; Coletta DK; Sriwijitkamol A; Musi N
Diabetes; 2008 Oct; 57(10):2595-602. PubMed ID: 18633101
[TBL] [Abstract][Full Text] [Related]
10. Fatty acid-induced insulin resistance in L6 myotubes is prevented by inhibition of activation and nuclear localization of nuclear factor kappa B.
Sinha S; Perdomo G; Brown NF; O'Doherty RM
J Biol Chem; 2004 Oct; 279(40):41294-301. PubMed ID: 15252018
[TBL] [Abstract][Full Text] [Related]
11. Lipoxin A4 inhibits TNF-alpha-induced production of interleukins and proliferation of rat mesangial cells.
Wu SH; Lu C; Dong L; Zhou GP; He ZG; Chen ZQ
Kidney Int; 2005 Jul; 68(1):35-46. PubMed ID: 15954894
[TBL] [Abstract][Full Text] [Related]
12. Palmitate and insulin synergistically induce IL-6 expression in human monocytes.
Bunn RC; Cockrell GE; Ou Y; Thrailkill KM; Lumpkin CK; Fowlkes JL
Cardiovasc Diabetol; 2010 Nov; 9():73. PubMed ID: 21054880
[TBL] [Abstract][Full Text] [Related]
13. Modulation of cellular insulin signaling and PTP1B effects by lipid metabolites in skeletal muscle cells.
Obanda DN; Cefalu WT
J Nutr Biochem; 2013 Aug; 24(8):1529-37. PubMed ID: 23481236
[TBL] [Abstract][Full Text] [Related]
14. Toll-like receptor-2 is essential for the development of palmitate-induced insulin resistance in myotubes.
Senn JJ
J Biol Chem; 2006 Sep; 281(37):26865-75. PubMed ID: 16798732
[TBL] [Abstract][Full Text] [Related]
15. A MEK inhibitor, PD98059 enhances IL-1-induced NF-kappaB activation by the enhanced and sustained degradation of IkappaBalpha.
Funakoshi M; Tago K; Sonoda Y; Tominaga S; Kasahara T
Biochem Biophys Res Commun; 2001 Apr; 283(1):248-54. PubMed ID: 11322796
[TBL] [Abstract][Full Text] [Related]
16. Prolonged exposure to palmitate impairs fatty acid oxidation despite activation of AMP-activated protein kinase in skeletal muscle cells.
Pimenta AS; Gaidhu MP; Habib S; So M; Fediuc S; Mirpourian M; Musheev M; Curi R; Ceddia RB
J Cell Physiol; 2008 Nov; 217(2):478-85. PubMed ID: 18561258
[TBL] [Abstract][Full Text] [Related]
17. Induction of protein catabolism in myotubes by 15(S)-hydroxyeicosatetraenoic acid through increased expression of the ubiquitin-proteasome pathway.
Whitehouse AS; Khal J; Tisdale MJ
Br J Cancer; 2003 Aug; 89(4):737-45. PubMed ID: 12915888
[TBL] [Abstract][Full Text] [Related]
18. Involvement of visfatin in palmitate-induced upregulation of inflammatory cytokines in hepatocytes.
Choi YJ; Choi SE; Ha ES; Kang Y; Han SJ; Kim DJ; Lee KW; Kim HJ
Metabolism; 2011 Dec; 60(12):1781-9. PubMed ID: 21664630
[TBL] [Abstract][Full Text] [Related]
19. Transient nuclear factor kappaB (NF-kappaB) activation stimulated by interleukin-1beta may be partly dependent on proteasome activity, but not phosphorylation and ubiquitination of the IkappaBalpha molecule, in C6 glioma cells. Regulation of NF-kappaB linked to chemokine production.
Uehara T; Matsuno J; Kaneko M; Nishiya T; Fujimuro M; Yokosawa H; Nomura Y
J Biol Chem; 1999 May; 274(22):15875-82. PubMed ID: 10336492
[TBL] [Abstract][Full Text] [Related]
20. HDL counterbalance the proinflammatory effect of oxidized LDL by inhibiting intracellular reactive oxygen species rise, proteasome activation, and subsequent NF-kappaB activation in smooth muscle cells.
Robbesyn F; Garcia V; Auge N; Vieira O; Frisach MF; Salvayre R; Negre-Salvayre A
FASEB J; 2003 Apr; 17(6):743-5. PubMed ID: 12586748
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
